Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells
Authors
Keywords
-
Journal
LEUKEMIA
Volume 31, Issue 1, Pages 65-74
Publisher
Springer Nature
Online
2016-05-25
DOI
10.1038/leu.2016.154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency
- (2016) Hui Zhang et al. Cell Stem Cell
- Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
- (2015) Stéphane Prost et al. NATURE
- Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells
- (2015) Andriana G Kotini et al. NATURE BIOTECHNOLOGY
- MEK and TGF-beta Inhibition Promotes Reprogramming without the Use of Transcription Factor
- (2015) Jan Vrbsky et al. PLoS One
- Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells
- (2015) Kran Suknuntha et al. Stem Cell Research
- Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11 -Associated Juvenile Myelomonocytic Leukemia
- (2015) Sonia Mulero-Navarro et al. Cell Reports
- Using induced pluripotent stem cells as a tool for modelling carcinogenesis
- (2015) Emma L Curry World Journal of Stem Cells
- Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition
- (2014) K. P. Ng et al. BLOOD
- Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming
- (2014) Guofang Chen et al. CELL RESEARCH
- Dedifferentiation and reprogramming: origins of cancer stem cells
- (2014) D. Friedmann-Morvinski et al. EMBO REPORTS
- Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy
- (2014) A. Mukhopadhyay et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Epigenetic reprogramming induces the expansion of cord blood stem cells
- (2014) Pratima Chaurasia et al. JOURNAL OF CLINICAL INVESTIGATION
- The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors
- (2014) Francesca Pellicano et al. STEM CELLS
- Metabolic Correction of Congenital Erythropoietic Porphyria with iPSCs Free of Reprogramming Factors
- (2013) Aurélie Bedel et al. AMERICAN JOURNAL OF HUMAN GENETICS
- OCT4: Dynamic DNA binding pioneers stem cell pluripotency
- (2013) Stepan Jerabek et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia
- (2013) S. Gandre-Babbe et al. BLOOD
- KIT Signaling Governs Differential Sensitivity of Mature and Primitive CML Progenitors to Tyrosine Kinase Inhibitors
- (2013) A. S. Corbin et al. CANCER RESEARCH
- Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells
- (2013) Y Liu et al. LEUKEMIA
- Variable Behavior of iPSCs Derived from CML Patients for Response to TKI and Hematopoietic Differentiation
- (2013) Aurélie Bedel et al. PLoS One
- Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples
- (2012) K. Kumano et al. BLOOD
- The expanding role of miR-302–367 in pluripotency and reprogramming
- (2012) Inna Lipchina et al. CELL CYCLE
- Serine 111 Phosphorylation Regulates OCT4A Protein Subcellular Distribution and Degradation
- (2012) Renza Spelat et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Off-target effects of BCR–ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia
- (2012) Juan Luis Steegmann et al. LEUKEMIA & LYMPHOMA
- Phosphorylation regulates human OCT4
- (2012) J. Brumbaugh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-302 Increases Reprogramming Efficiency via Repression of NR2F2
- (2012) Shijun Hu et al. STEM CELLS
- iPSCs from cancer cells: challenges and opportunities
- (2012) Verónica Ramos-Mejia et al. TRENDS IN MOLECULAR MEDICINE
- Fatherhood during imatinib
- (2011) Emad Shash et al. ACTA ONCOLOGICA
- Pan-Src Family Kinase Inhibitors Replace Sox2 during the Direct Reprogramming of Somatic Cells
- (2011) Judith Staerk et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
- (2011) A. Hamilton et al. BLOOD
- Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease
- (2011) J.-C. Chomel et al. BLOOD
- Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells
- (2011) K. Hu et al. BLOOD
- Molecular Pathways: BCR-ABL
- (2011) D. Cilloni et al. CLINICAL CANCER RESEARCH
- Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks: Figure 1.
- (2011) Francesca Pellicano et al. JOURNAL OF EXPERIMENTAL MEDICINE
- microRNAs become macro players in somatic cell reprogramming
- (2011) Tamer T Onder et al. Genome Medicine
- BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells
- (2010) M. Schemionek et al. BLOOD
- Generation of iPSCs from cultured human malignant cells
- (2010) J. E. Carette et al. BLOOD
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- The stem cell factor–c-KIT pathway must be inhibited to enable apoptosis induced by BCR–ABL inhibitors in chronic myelogenous leukemia cells
- (2009) F Belloc et al. LEUKEMIA
- IFNα activates dormant haematopoietic stem cells in vivo
- (2009) Marieke A. G. Essers et al. NATURE
- The effects of imatinib on pregnancy outcome
- (2008) S. M. Pye et al. BLOOD
- A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells
- (2008) Yan Shi et al. Cell Stem Cell
- Embryonic Stem Cell-Specific miR302-367 Cluster: Human Gene Structure and Functional Characterization of Its Core Promoter
- (2008) A. Barroso-delJesus et al. MOLECULAR AND CELLULAR BIOLOGY
- CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells
- (2008) L. Jin et al. MOLECULAR CANCER THERAPEUTICS
- The ground state of embryonic stem cell self-renewal
- (2008) Qi-Long Ying et al. NATURE
- Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition
- (2008) Jose Silva et al. PLOS BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started